The third component of the complement (C3) is a marker of the risk of atherogenesis

Vincenzo Capuano1, Teodora D'Arminio, Giuseppe La Sala

  • 1Unità Operativa di Cardiologia ed UTIC - Ospedale Amico G. Fucito Mercato San Severino (SA), Genova, Italy. capuanov@tiscalinet.it

Insights

High levels of the third component of complement (C3) are linked to increased coronary heart disease risk factors. This finding suggests C3 may indicate a predisposition to atherogenesis.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Biochemistry

Background:

  • Coronary heart disease (CHD) is a leading cause of mortality worldwide.
  • Identifying novel risk factors for CHD is crucial for effective prevention strategies.
  • The complement system, particularly C3, plays a role in inflammatory processes implicated in atherosclerosis.

Purpose of the Study:

  • To investigate the association between serum C3 concentrations and established CHD risk factors.
  • To determine if C3 is an independent predictor of CHD risk.
  • To explore the relationship between C3 and metabolic and hemostatic parameters.

Main Methods:

  • Cross-sectional study involving 1200 individuals (600 men, 600 women) aged 25-74 years.
  • Serum C3 levels were measured and correlated with various risk factors.
  • Statistical analyses were performed to assess significant associations and independent correlations.

Main Results:

  • A significant positive correlation was observed between serum C3 and body mass index (BMI) and fibrinogen.
  • Independent correlations were found between C3 and platelet count, insulin levels, triglycerides, and low-density lipoprotein (LDL) cholesterol.
  • An inverse correlation was noted between C3 levels and cigarette smoking.

Conclusions:

  • Elevated serum C3 concentration is associated with a cluster of CHD risk factors.
  • High C3 levels may serve as a marker for an atherogenic risk profile.
  • Further research is warranted to elucidate the causal role of C3 in atherogenesis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...